Blood pressure and metabolic responses to moderate sodium restriction in isradipine-treated hypertensive patients

American Journal of Hypertension

Volumn 10, Issue 1, 1997, Pages 68-76

  McCarron, David A ^a   Weder, Alan B ^b   Egan, Brent M ^c   Krishna, Gopal G ^d   Morris, Cynthia D ^a   Cohen, Michael ^e   Oparil, Suzanne ^f  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

^c MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

^e Sandoz Pharma Ltd   (Switzerland)

^f UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

antihyperetensive medications; blood pressure; calcium channel blockers; hypertension; lipids; sodium restriction; sodium dietary

Indexed keywords

CALCIUM CHANNEL BLOCKING AGENT; ISRADIPINE; PLACEBO; SODIUM CHLORIDE;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; HUMAN; HYPERTENSION; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SODIUM EXCRETION; SODIUM RESTRICTION;

ADULT; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; FEMALE; HUMANS; HYPERTENSION; ISRADIPINE; MALE; MIDDLE AGED; SODIUM CHLORIDE, DIETARY;

EID: 0031016032     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0895-7061(96)00295-6     Document Type: Article

References (25)

1. Midgley JP, Matthew AG, Greenwood CMT, Logan AG. Effect of reduced dietary sodium on blood pressure: a meta-analysis of randomized controlled trials. JAMA. 275:1996;1590-1597.
2. Resnick LM, Gupta RJ, DiFabio B, et al. Intracellular ionic consequences of dietary salt loading in essential hypertension. Relation of blood pressure and effects of calcium channel blockade. J Clin Invest. 94:1994;1269-1276.
3. Morgan T, Anderson A, Wilson D, et al. Paradoxical effect of sodium restriction on blood pressure in people on slow-channel calcium blocking drugs (letter). Lancet. i:1986;793.
4. Ritz E, Schmid M, Ji-Zhen G, Mann J. Salt and the action of calcium antagonists. J Cardiovasc Pharmacol. 12:((suppl 6)):1988;S53-S56.
5. Leonetti G, Rupoli L, Gradnik R, Zanchetti A. Effects of a low-sodium diet on antihypertensive and natriuretic responses to acute administration of nifedipine. J Hypertens. 5:((suppl 4)):1987;S57-S60.
6. Luft FC, Fineberg NS, Weinberger MH. Long-term effect of nifedipine and hydrochlorothiazide on blood pressure and sodium homeostasis at varying levels of salt intake in mildly hypertensive patients. Am J Hypertens. 4:1991;752-760.
7. Cappuccio FP, Markandu ND, Sagnella GA, et al. Acute and sustained changes in sodium balance during nifedipine treatment in essential hypertension. Am J Med. 91:1991;233-238.
8. Nicholson JP, Resnick LM, Laragh JH. The antihypertensive effect of verapamil at extremes of dietary sodium intake. Ann Intern Med. 107:1987;329-334.
9. Luque-Otero M, Fernandez-Pinilla C, Catalan P. Acute antihypertensive effect of nifedipine on high and low salt diet. J Cardiovasc Pharmacol. 10:((suppl 10)):1987;S147-S148.
10. Redon-Mas J, Abellan-Aleman J, Aranda-Lara P. Antihypertensive activity of verapamil: impact of dietary sodium. J Hypertens. 11:1993;665-671.
11. Parijs J, Joossens JC, Van der Linden, et al. Moderate sodium restriction and diuretics with the treatment of hypertension. Am Heart J. 85:1973;22-34.
12. Erwteman TM, Nagelkerke N, Lubsen J, et al. β -Blockade, diuretics, and salt restriction for the management of mild hypertension: a randomised double blind trial. Br Med J. 289:1984;406-409.
13. MacGregor GA, Markandu ND, Singer DRJ. Moderate sodium restriction with angiotensin converting enzyme inhibitor in essential hypertension: a double blind study. Br Med J. 294:1987;531-534.
14. Morris C, Rufolo P, Snyder G, McCarron D. Impact of dietary NaCl restriction on overall nutrient intake (abst). Am J Hypertens. 7:1994;61A.
15. Intersalt: an international study of electrolyte excretion and blood pressure. Results for 24-h urinary sodium and potassium excretion. Br Med J. 297:1988;319-328.
16. The fifth report of the Joint National Committee on Detection, Evaluation and Treatment of High Blood Pressure. Arch Intern Med. 153:1993;154-183.
17. Miller JZ, Weinberger MH, Daugherty S, et al. Heterogeneity of blood pressure response to dietary sodium restriction in normotensive adults. J Chonic Dis. 40:1987;245-250.
18. Longworth DK, Drayer JIM, Weber MA, Laragh JH. Divergent blood pressure responses during short-term sodium restriction in hypertension. Clin Pharmacol Ther. 27:1980;544-546.
19. Weinberger MH, Miller JZ, Luft FC, et al. Definitions and characteristics of sodium sensitivity and blood pressure resistance. Hypertension. 8:1986;II-127-II-134.
20. Weder AB, Egan BM. Potential deleterious effects of short-term dietary salt restriction on cardiovascular risk factors. Klin Wochensch. 69:((suppl XXV)):1991;45-50.
21. Masugi F, Ogihara T, Hashizume K, et al. Changes in plasma lipids and uric acid with sodium loading and sodium depletion in patients with essential hypertension. J Hum Hypertens. 1:1988;293-298.
22. Sharma AM, Arntz H, Kribben A, et al. Dietary sodium restriction: adverse effect on plasma lipids. Klin Wochensch. 68:1990;664-668.
23. Ruppert M, Diehl J, Kolloch R, et al. Short-term dietary sodium restriction increases serum lipids and insulin in salt-sensitive and salt-resistant normotensive adults. Klin Wochensch. 69:((suppl XXV)):1991;51-57.
24. Alderman MH, Madhavan S, Ooi WL, et al. Association of the renin-sodium profile with the risk of myocardial infarction in patients with hypertension. N Engl J Med. 324:1991;1098-1104.
25. Alderman MH, Madhavan S, Cohen H, et al. Low urinary sodium is associated with greater risk of myocardial infarction among treated hypertensive men. Hypertension. 25:1995;1144-1152.